Audience: interventional radiology leads, oncology service planners, biomedical engineers, and distributors evaluating thermal ablation capital and consumables. Educational overview only — not a substitute for IFU, institutional tumor-board protocols, or reimbursement rules.
Ablation programs require alignment between imaging modality (US, CT, MRI-conditional where cleared), electrode/applicator inventory, generator calibration, and pathology or imaging follow-up workflows. BBT's interventional portfolio spans dedicated RF ablation platforms and window/visualization-oriented systems marketed for selected solid-lesion applications per regional labels.